Sort   by:  
 Page size 
UnknownExpert perspectives on biosimilar monoclonal antibodies in breast cancer.
Not available
S-EPMC3949011 | biostudies-literature
UnknownGlobal research progress in antibody-drug conjugates for solid tumors: Bibliometrics and visualized analysis.
Not available
S-EPMC11869778 | biostudies-literature
UnknownCommentary: SARS-CoV-2 vaccines and cancer patients.
Not available
S-EPMC7831848 | biostudies-literature
UnknownAre all cyclin-dependent kinases 4/6 inhibitors created equal?
Not available
S-EPMC6715721 | biostudies-literature
UnknownAccelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021.
Not available
S-EPMC9097802 | biostudies-literature
UnknownCombinations using checkpoint blockade to overcome resistance.
Not available
S-EPMC7864692 | biostudies-literature
UnknownRecent advances in triple negative breast cancer: the immunotherapy era.
Not available
S-EPMC6507064 | biostudies-literature
UnknownFuture perspectives in cancer immunotherapy.
Not available
S-EPMC4971381 | biostudies-literature
UnknownMismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy.
Not available
S-EPMC5523547 | biostudies-literature
UnknownToward precision medicine in inflammatory breast cancer.
Not available
S-EPMC8798747 | biostudies-literature
Sort   by:  
 Page size